4BASEBIO PLC (4BB) — Investor Presentation

Investor webinar replay

Replay transcript excerpt

Good morning, ladies and gentlemen, and welcome to the 4BASEBIO PLC Investor Presentation. Q and A tab that's just situated on the right hand corner of your screen. Please just simply type in your questions and press send. The company may not be in a position to answer every question it receives during the meeting itself. However, the company can review all questions submitted today and we'll publish those responses where it's appropriate to do so on the investor meet company platform. And before we begin, I would just like to submit the following poll. And if you could give that your kind attention, I'm sure the company would be most grateful. I would now like to hand you over to the executive management team from 4BASEBIO PLC. Heikki, good morning, sir. Thank you, Jake, and thank you everybody for for joining us today for the the the usual annual company update. We're excited to have so many people join us, and there's quite a few positive messages to to bring today. Before we start, we have the the usual disclaimer, so I'll give you a couple of seconds to just read through that. And then we'll start with introducing ourselves. So you're very familiar with David and myself. We've done a few of these presentations before. But today, I would like to introduce you to doctor Amy Walker as well who will be joining us in this presentation and provide some further detail on some of the commercial development and competitive differentiators of our technology. So Amy, maybe you can introduce yourself. Thank you. So and my name is Amy Walker. I am the VP of research and BD here at 4BASEBIO. My background is in molecular biology and nonbio delivery systems, and my core responsibilities at the company are the developer development of our two technology platforms and their comm...